300702.SZ
天宇股份
SZSE · Healthcare · C 制造业 · CN
CNY 21.48
−2.50%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
16.4x
Market Cap
CNY 7.47B
MomentumView details →
1D Return
−2.50%
YTD Return
−8.39%
RSI (14)
50.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
16.4x
Market Cap
CNY 7.47B
RSI (14)
50.7
MomentumView details →
1D Return
−2.50%
YTD Return
−8.39%
Similar companies
Latest newsMore news →
Tianyu Pharmaceutical's wholly-owned subsidiary Zhejiang Jingsheng Pharmaceutical's sitagliptin phosphate API passed the review by China's Center for Drug Evaluation (CDE).9h agoTianyu Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 104 million yuan, down 32.12% year-on-year, with revenue of 2.011 billion yuan, up 13.23%.8d ago